Volume 17, Number 10—October 2011
Letter
Complicated Pandemic (H1N1) 2009 during Pregnancy, Taiwan
Table
Characteristic | Pregnant, n = 10 | Nonpregnant, n = 138 | p value† |
---|---|---|---|
Age, y | 24.5 (22–32) | 27.5 (15–49) | 0.39 |
ACIP high-risk condition other than pregnancy |
0 |
28 (20) |
0.21 |
Pneumonia | 9 (90) | 134 (97) | 0.30 |
ARDS |
5 (50) |
14 (10) |
0.003 |
Admission to hospital | 9 (90) | 138 (100) | 0.07 |
Time from symptom onset to hospitalization, d | 2 (0–7) | 2 (1–12) | 0.78 |
Length of hospital stay, d |
8 (3–47) |
5 (0–100) |
0.03 |
Admission to ICU | 5 (50) | 31 (22) | 0.06 |
Length of ICU stay, d |
16 (6–33) |
5 (0–83) |
0.07 |
Oseltamivir treatment | 9 (90) | 135 (98) | 0.25 |
<48 h after illness onset |
4 (40) |
84‡ (63) |
0.19 |
Mechanical ventilation | 5 (50) | 19 (14) | 0.01 |
ECMO |
3 (30) |
1 (1) |
<0.001 |
Death | 3 (30) | 5 (4) | 0.01 |
Time from illness onset to death, d | 16 (2–37) | 9 (1–32) | 0.57 |
*Values are median (range) or no. (%). ACIP, Advisory Committee on Immunization Practices; ARDS, acute respiratory distress syndrome; ICU, intensive care unit; ECMO, extracorporeal membrane oxygenation.
†Medians were compared by using Wilcoxon rank-sum test, and proportions were compared by using Fisher exact test.
‡For 4 nonpregnant women, information on date of initiation of oseltamivir treatment was unknown.
Page created: September 27, 2011
Page updated: September 27, 2011
Page reviewed: September 27, 2011
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.